Triomics
Triomics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 3 tracked investors.
About Triomics
Triomics is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Triomics develops generative AI solutions for oncology, focusing on cancer care operations and research. The company provides a platform that automates clinical trial matching, pre-visit chart review and preparation, and oncology data abstraction for registries, quality improvement and operational work.
Explore Triomics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.